Mannatech (MTEX) AI Stock Analysis

• Market Cap: $15.60M
• Dividend Yield: N/A
• Average Volume (3M): 14.01K
• Price to Earnings (P/E): 8.9
• Beta (1Y): 0.50
• Revenue Growth: -9.59%
• EPS Growth: 87.78%
• Country: US
• Employees: 189
• Sector: Consumer Defensive
• Sector Strength: 55
• Industry: Household & Personal Products
• EPS (TTM): -0.81
• Shares Outstanding: 1,900,930
• 10 Day Avg. Volume: 7,644
• 30 Day Avg. Volume: 14,006
• PEG Ratio: 0.66
• Price to Book (P/B): 2.06
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -19.15
• Enterprise Value/Market Cap: 0.74
• Enterprise Value/Revenue: 0.02
• Enterprise Value/Gross Profit: 0.13
• Enterprise Value/Ebitda: 1.77
• 1Y Price Target: $9.50
• Price Target Upside: 15.85% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 44 Neutral
• Price Target: $8.00 ▼(-2.44%Downside)

Mannatech's overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. The potential operational improvements from the recent COO promotion provide some positive outlook, but significant challenges in profitability and cash flow remain the dominant factors affecting the score.

Mannatech Business Overview & Revenue Model

Company Description

Mannatech, Incorporated (MTEX) is a global health and wellness company that develops, markets, and sells nutritional supplements, topical and skin care products, and weight-management solutions. Founded in 1993 and headquartered in Flower Mound, Texas, Mannatech operates in the direct selling industry, leveraging a network of independent sales associates to distribute its proprietary products. The company is particularly known for its focus on glyconutrient technology, which it incorporates into many of its offerings to support overall wellness and health.

How the Company Makes Money

Mannatech generates revenue primarily through the sale of its health and wellness products, which are distributed via a direct selling model. This involves a network of independent sales associates who earn commissions by selling products directly to consumers and recruiting new associates. The company’s key revenue streams include its line of nutritional supplements, which are formulated with their proprietary glyconutrient technology, as well as skin care and weight-management products. Mannatech's earnings are significantly influenced by the size and productivity of its sales associate base, the effectiveness of its incentive programs, and its ability to innovate and market new products effectively. Additionally, the company occasionally enters into partnerships or strategic collaborations to expand its market reach and enhance its product offerings.

Mannatech Financial Statement Overview

Summary

Mannatech faces significant financial challenges with declining revenue and negative profitability. The income statement reveals a negative net income, and cash flow analysis shows negative free cash flow and operational inefficiencies. The balance sheet indicates moderate financial leverage but decreasing equity levels, raising liquidity concerns.

Income Statement

Mannatech's income statement indicates a declining trend in revenue and profitability. The TTM (Trailing-Twelve-Months) shows negative net income of -$220,000 and a negative EBIT, reflecting struggles in operational efficiency. Gross profit margin remains stable at around 76.6% in TTM, but the net profit margin has turned negative due to a significant drop in revenue from $159.8 million in 2021 to $115.0 million in TTM. These challenges highlight issues in scaling operations profitably.

Balance Sheet

The balance sheet shows a high level of liabilities compared to equity, with a debt-to-equity ratio of 0.67 in TTM, indicating moderate financial leverage. The equity ratio has decreased to 20.7% from 43.1% in 2020, showing a declining reliance on equity financing. The company maintains a cash position of $9.3 million, but the shrinking stockholders' equity from $24.4 million in 2021 to $7.6 million in TTM suggests potential liquidity concerns if liabilities continue to rise.

Cash Flow

Cash flow analysis reveals declining free cash flow, which turned negative at -$814,000 in TTM, despite positive developments in previous years. The operating cash flow has drastically declined from $10.8 million in 2021 to -$981,000 in TTM, raising concerns about cash generation from core operations. The operating cash flow to net income ratio is negative, indicating inefficiencies in converting profits into cash.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	117.87M	131.96M	137.21M	159.76M	151.41M
Gross Profit	91.46M	102.86M	104.15M	125.61M	115.90M
EBITDA	5.55M	702.00K	1.22M	10.77M	6.48M
Net Income	2.49M	-2.24M	-4.49M	9.84M	6.26M
Balance Sheet
Total Assets	36.06M	41.21M	49.13M	59.63M	65.34M
Cash, Cash Equivalents and Short-Term Investments	11.40M	7.73M	13.78M	24.18M	22.21M
Total Debt	6.69M	5.73M	6.21M	339.00K	758.00K
Total Liabilities	27.44M	30.72M	34.95M	35.21M	39.36M
Stockholders Equity	8.61M	10.48M	14.18M	24.41M	25.97M
Cash Flow
Free Cash Flow	1.96M	-3.12M	-3.66M	10.12M	5.08M
Operating Cash Flow	2.26M	-2.37M	-2.60M	10.77M	6.03M
Investing Cash Flow	-285.00K	-747.00K	-1.06M	-650.00K	-947.00K
Financing Cash Flow	1.96M	-1.90M	-4.33M	-9.29M	-9.92M

Mannatech Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 8.20
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Negative. The current price of 8.2 is below the 20-day moving average (MA) of 8.99, below the 50-day MA of 9.71, and below the 200-day MA of 9.98, indicating a bearish trend. The MACD of -0.42 indicates Positive momentum. The RSI at 37.43 is Neutral, neither overbought nor oversold. The STOCH value of 8.94 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTEX.

Mannatech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UG	71 Outperform	$37.26M	12.91	26.24%	8.63%	11.91%	25.93%
TKLF	70 Outperform	$17.74M	2.71	16.79%	―	―	―
Sector *	65 Neutral	$26.77B	15.22	-4.18%	3.21%	1.01%	1.53%
TANH	54 Neutral	$2.53M	1.82	-1.68%	―	-9.25%	-109.49%
SKIN	54 Neutral	$206.66M	―	-70.44%	―	-17.97%	49.13%
MTEX	44 Neutral	$15.60M	8.92	-2.44%	―	-9.59%	87.78%
GROV	41 Neutral	$58.63M	―	-180.03%	―	-19.83%	22.76%

Mannatech Corporate Events

Mannatech Promotes Peter Griscom to COO Role

On June 26, 2025, Mannatech announced the promotion of Peter Griscom to Chief Operating Officer, effective July 1, 2025. Griscom, who has extensive experience in the consumer goods space and direct selling channel, previously served as the senior vice president of global operations. His promotion is expected to enhance operational efficiencies and streamline processes, positively impacting the company’s future.

Mannatech Approves Proposals at Annual Shareholders’ Meeting

On June 3, 2025, Mannatech, Incorporated held its annual shareholders’ meeting where all proposals were approved by the shareholders. The meeting saw the election of J. Stanley Fredrick and Tyler J. Rameson as Class II directors, the ratification of BDO USA, P.C. as the independent public accounting firm, and advisory approvals on executive compensation and its voting frequency. Approximately 77.8% of the total shares were represented at the meeting, indicating strong shareholder engagement.